tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
ADAP
Adaptimmune Therapeutics
Stock Analysis
Analyst Forecasts
News & Insights
Technical Analysis
Options
Chart
Earnings
Dividends
Ownership
Financials
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding ADAP?
Track your performance easily
Link Broker

Adaptimmune Therapeutics (ADAP) Stock News & Sentiment

804 Followers
Adaptimmune’s Strategic Shift and Financial Update
Premium
Company Announcements
Adaptimmune’s Strategic Shift and Financial Update
3d ago
ADAP
Is ADAP a Buy, Before Earnings?
Premium
Pre-Earnings
Is ADAP a Buy, Before Earnings?
6d ago
ADAP
Adaptimmune Therapeutics Plc. (ADAP) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Adaptimmune Therapeutics Plc. (ADAP) Q2 Earnings Cheat Sheet
3M ago
ADAP
Adaptimmune’s TECELRA®: FDA Approval Marks Solid Tumor Breakthrough
Premium
Company Announcements
Adaptimmune’s TECELRA®: FDA Approval Marks Solid Tumor Breakthrough
4M ago
8K
ADAP
Adaptimmune Enhances Severance Benefits for Executives
Premium
Company Announcements
Adaptimmune Enhances Severance Benefits for Executives
4M ago
8K
ADAP
Adaptimmune Enhances Executive Severance and Benefit Terms
Premium
Company Announcements
Adaptimmune Enhances Executive Severance and Benefit Terms
5M ago
8K
ADAP
Adaptimmune Inks Lucrative Deal for Cancer Therapy Trial
Premium
Company Announcements
Adaptimmune Inks Lucrative Deal for Cancer Therapy Trial
6M ago
8K
ADAP
More ADAP News >

ADAP News on the Web

Adaptimmune Therapeutics: Strategic Realignment and Cautious Optimism for Future Growth
TipRanks News
Neutral
Halozyme bids for Evotec; BeiGene gets a new name
BioPharma Dive
Neutral
Adaptimmune nears second sarcoma approval as Phase II trial hits endpoints
Pharmaceutical Technology
Bullish
OTC Markets Hosts Virtual Investor Presentation with Adrian Rawcliffe, CEO of Adaptimmune Therapeutics, and Michael Kim, Senior Analyst at Zacks SCR
Yahoo Finance
Neutral
Adaptimmune Therapeutics plc's top owners are individual investors with 39% stake, while 28% is held by institutions
Yahoo Finance
Neutral
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Yahoo Finance
Neutral
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
Yahoo Finance
Neutral
Biotech Stocks Facing FDA Decision In September 2024
rttnews
Neutral

News Score - Last 7 Days

Neutral
ADAP
Sector Average
Media Buzz
This Week3 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average63%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ADAP’s Media Buzz Sentiment?
3 articles about ADAP were published this week. In an average week, 1 articles are published.
    What is ADAP’s weekly average amount of articles?
    In an average week, 1 articles about ADAP are published.
      What is ADAP’s News Sentiment?
      100% of articles about ADAP were positive this week, compared to its sector average of 63%.
        Healthcare Stocks that are Trending in the News
        ACRVAcrivon Therapeutics, Inc.
        MRSNMersana Therapeutics
        PHNPharmaNutra SpA
        NVCTNuvectis Pharma
        VRDNViridian Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing